As the global economy recovers in 2021 and the supply of the industrial chain improves, the CAR T-cell Therapy Drug market will undergo major changes. According to the latest research, the market size of the CAR T-cell Therapy Drug industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global CAR T-cell Therapy Drug industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global CAR T-cell Therapy Drug market during the next few years. The global CAR T-cell Therapy Drug market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The CAR T-cell Therapy Drug market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Player list
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Types list
CD19-targeted
BCMA-targeted
Application list
Lymphoma
Multiple Myeloma
Table of Content
1 CAR T-cell Therapy Drug Market Scope Analysis Introduction
1.1 CAR T-cell Therapy Drug Product Definition and Scope Introduction
1.2 CAR T-cell Therapy Drug Market dynamics
1.3 CAR T-cell Therapy Drug Market Segmentation
1.3.1 CAR T-cell Therapy Drug Segment by Type
1.3.2 CAR T-cell Therapy Drug Segment by Applications
1.4 Report Timeline
2 Methodology and Data Source
2.1 Methodology/Research Approach
2.1.1 Research Programs/Design
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
2.2.3 Legal Disclaimer
3 Analysis of key market players
3.1 Novartis
3.1.1 Business Overview
3.1.2 CAR T-cell Therapy Drug Product Introduction
3.1.3 Novartis CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
3.2 Gilead Sciences
3.2.1 Business Overview
3.2.2 CAR T-cell Therapy Drug Product Introduction
3.2.3 Gilead Sciences CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
3.3 Bristol-Myers Squibb
3.3.1 Business Overview
3.3.2 CAR T-cell Therapy Drug Product Introduction
3.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
3.4 J & J
3.4.1 Business Overview
3.4.2 CAR T-cell Therapy Drug Product Introduction
3.4.3 J & J CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
3.5 JW Therapeutics
3.5.1 Business Overview
3.5.2 CAR T-cell Therapy Drug Product Introduction
3.5.3 JW Therapeutics CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
3.6 FOSUNKite
3.6.1 Business Overview
3.6.2 CAR T-cell Therapy Drug Product Introduction
3.6.3 FOSUNKite CAR T-cell Therapy Drug Sales, Price, Revenue, Gross Margin
4 CAR T-cell Therapy Drug Historical and Forecast Market Size by Type
4.1 CAR T-cell Therapy Drug Market Historical Size by Type (2017-2022)
4.2 CAR T-cell Therapy Drug Market Forecast Size by Type (2023-2028)
5 CAR T-cell Therapy Drug Historical and Forecast Market Size by Application
5.1 CAR T-cell Therapy Drug Market Historical Size by Application (2017-2022)
5.2 CAR T-cell Therapy Drug Market Forecast Size by Application (2023-2028)
6 CAR T-cell Therapy Drug Historical and Forecast Market Size by Region
6.1 CAR T-cell Therapy Drug Historical and Forecast Sales Market Size by Region
6.2 CAR T-cell Therapy Drug Historical and Forecast Revenue Market Size by Region
6.3 CAR T-cell Therapy Drug Historical and Forecast Market Size by Country
6.3.1 CAR T-cell Therapy Drug Historical and Forecast Sales Market Size by Country (2017-2028)
6.3.1.1 United States CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.2 Canada CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.3 Germany CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.4 UK CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.5 France CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.6 Italy CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.7 Russia CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.5 China CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.6 Japan CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.7 Southeast Asia CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.8 Korea CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.9 India CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.10 Brazil CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.1.11 Mexico CAR T-cell Therapy Drug Sales and Growth (2017-2028)
6.3.2 CAR T-cell Therapy Drug Historical and Forecast Revenue Market Size by Country (2017-2028)
6.3.2.1 United States CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.2 Canada CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.3 Germany CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.4 UK CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.5 France CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.6 Italy CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.7 Russia CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.5 China CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.6 Japan CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.7 Southeast Asia CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.8 Korea CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.9 India CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.10 Brazil CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
6.3.2.11 Mexico CAR T-cell Therapy Drug Revenue and Growth (2017-2028)
7 CAR T-cell Therapy Drug Market Dynamics
7.1 Market Drivers
7.2 Market Restraints
7.3 Opportunity
7.4 Market Trends
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 CAR T-cell Therapy Drug Distributors List
8.3 CAR T-cell Therapy Drug Customers
9 Research Findings and Conclusion
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/north-america[2] https://www.marketresearchreports.com/countries/europe[3] https://www.marketresearchreports.com/countries/china[4] https://www.marketresearchreports.com/countries/japan[5] https://www.marketresearchreports.com/countries/global[6] https://www.marketresearchreports.com/healthcare[7] https://www.marketresearchreports.com/pharma-healthcare